You can:
Name | Galanin receptor type 3 |
---|---|
Species | Homo sapiens (Human) |
Gene | GALR3 |
Synonym | GAL3-R Galnr3 GALR-3 GALR3 GAL3 receptor |
Disease | Cognitive disorders |
Length | 368 |
Amino acid sequence | MADAQNISLDSPGSVGAVAVPVVFALIFLLGTVGNGLVLAVLLQPGPSAWQEPGSTTDLFILNLAVADLCFILCCVPFQATIYTLDAWLFGALVCKAVHLLIYLTMYASSFTLAAVSVDRYLAVRHPLRSRALRTPRNARAAVGLVWLLAALFSAPYLSYYGTVRYGALELCVPAWEDARRRALDVATFAAGYLLPVAVVSLAYGRTLRFLWAAVGPAGAAAAEARRRATGRAGRAMLAVAALYALCWGPHHALILCFWYGRFAFSPATYACRLASHCLAYANSCLNPLVYALASRHFRARFRRLWPCGRRRRHRARRALRRVRPASSGPPGCPGDARPSGRLLAGGGQGPEPREGPVHGGEAARGPE |
UniProt | O60755 |
Protein Data Bank | N/A |
GPCR-HGmod model | O60755 |
3D structure model | This predicted structure model is from GPCR-EXP O60755. |
BioLiP | N/A |
Therapeutic Target Database | T98494 |
ChEMBL | CHEMBL2731 |
IUPHAR | 245 |
DrugBank | N/A |
Name | MLS001180182 |
---|---|
Molecular formula | C14H14N4S2 |
IUPAC name | 4-(2,4-dimethyl-1,3-thiazol-5-yl)-N-(4-methylpyridin-2-yl)-1,3-thiazol-2-amine |
Molecular weight | 302.414 |
Hydrogen bond acceptor | 6 |
Hydrogen bond donor | 1 |
XlogP | 4.0 |
Synonyms | MCULE-3732896271 [4-(2,4-dimethylthiazol-5-yl)thiazol-2-yl]-(4-methyl-2-pyridyl)amine;hydrobromide AKOS001700994 N-(4-methyl-2-pyridinyl)-N-[2',4'-dimethyl-4,5'-bis(1,3-thiazole)-2-yl]amine 4-(2,4-dimethyl-1,3-thiazol-5-yl)-N-(4-methylpyridin-2-yl)-1,3-thiazol-2-amine;hydrobromide [ Show all ] |
Inchi Key | GSIAWGVMMLXTJT-UHFFFAOYSA-N |
Inchi ID | InChI=1S/C14H14N4S2/c1-8-4-5-15-12(6-8)18-14-17-11(7-19-14)13-9(2)16-10(3)20-13/h4-7H,1-3H3,(H,15,17,18) |
PubChem CID | 2877322 |
ChEMBL | N/A |
IUPHAR | N/A |
BindingDB | 97133 |
DrugBank | N/A |
Structure | |
Lipinski's druglikeness | This ligand satisfies Lipinski's rule of five. |
Parameter | Value | Reference | Database source |
---|---|---|---|
IC50 | <29961.0 nM | N/A | BindingDB |
zhanglabzhanggroup.org | (734) 647-1549 | 100 Washtenaw Avenue, Ann Arbor, MI 48109-2218